EP3641769

1-[(2,3,4-TRIMETHOXYPHENYL)METHYL]-PIPERAZINE DERIVATIVE, COMPOSITIONS THEREOF AND METHODS FOR INCREASING EFFICIENCY OF CARDIAC METABOLISM

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    18.6.2018
  • EP published:
    8.6.2022
  • EP application number:
    18821590.9
  • Max expiry date:
    17.6.2038
  • Title in English:
    1-[(2,3,4-TRIMETHOXYPHENYL)METHYL]-PIPERAZINE DERIVATIVE, COMPOSITIONS THEREOF AND METHODS FOR INCREASING EFFICIENCY OF CARDIAC METABOLISM
  • Language of the patent:
    English

Timeline

Today
18.6.2018EP application
8.6.2022EP Publication

Owner

  • Name:
    Imbria Pharmaceuticals, Inc.
  • Address:
    12770 High Bluff Drive, Suite 270, San Diego, CA 92130, US

Inventor

  • Name:
    LEVIN, Andrew
  • Address:
    Newton, MA 02458, US

Priority

  • Number:
    201762522214 P
  • Date:
    20.6.2017
  • Country:
    US
  • Number:
    201762524237 P
  • Date:
    23.6.2017
  • Country:
    US
  • Number:
    201862710316 P
  • Date:
    16.2.2018
  • Country:
    US
  • Number:
    201862637434 P
  • Date:
    2.3.2018
  • Country:
    US
  • Number:
    201862647926 P
  • Date:
    26.3.2018
  • Country:
    US

Classification

  • Categories:
    C07D 213/80, A61K 31/455, A61K 31/495, A61K 31/55, A61P 3/00, A61P 9/00, A61P 21/00

Upload documents